Arthritis drug may help fight severe coronavirus cases, study finds

An arthritis drug may actually save lives in severe cases of coronavirus, according to a report. Tocilizumab — which is sold under the brand names RoAcemtra and Actemra to help treat rheumatoid arthritis — showed “clinical benefit” in patients who had the virus according to an unpublished study conducted by Paris university hospital trust, Canada’s… Continue reading at New York Post